Loading...
MLOCT logo

Octopus Biosafety SAENXTPA:MLOCT Stock Report

Market Cap €26.7m
Share Price
€0.21
My Fair Value
n/a
1Y24.3%
7D6.1%
Portfolio Value
View

Octopus Biosafety SA

ENXTPA:MLOCT Stock Report

Market Cap: €26.7m

Octopus Biosafety (MLOCT) Stock Overview

Engages in designing, manufacturing, and marketing of mobile, autonomous, intelligent, and modular robots for poultry industry in France and internationally. More details

MLOCT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

MLOCT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Community Contributor
US$3.87FV 1.0% overvalued intrinsic discount
30972.3%Revenue growth p.a.
162
0
0
4
9d ago

Octopus Biosafety SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Octopus Biosafety
Historical stock prices
Current Share Price€0.21
52 Week High€0.50
52 Week Low€0.092
Beta-0.039
1 Month Change0%
3 Month Change10.53%
1 Year Change24.26%
3 Year Change-37.13%
5 Year Change-81.08%
Change since IPO-98.61%

Recent News & Updates

Recent updates

Shareholder Returns

MLOCTFR MachineryFR Market
7D6.1%-0.4%-1.4%
1Y24.3%-17.5%1.9%

Return vs Industry: MLOCT exceeded the French Machinery industry which returned -20% over the past year.

Return vs Market: MLOCT exceeded the French Market which returned 1.2% over the past year.

Price Volatility

Is MLOCT's price volatile compared to industry and market?
MLOCT volatility
MLOCT Average Weekly Movement15.7%
Machinery Industry Average Movement5.8%
Market Average Movement5.3%
10% most volatile stocks in FR Market10.3%
10% least volatile stocks in FR Market2.9%

Stable Share Price: MLOCT's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: MLOCT's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
19876Bertrand Vergnewww.octopusbiosafety.com

Octopus Biosafety SA engages in designing, manufacturing, and marketing of mobile, autonomous, intelligent, and modular robots for poultry industry in France and internationally. It offers XO, a continuous litter treatment, and environmental and animal monitoring solution for poultry farming; T-MOOV, a robot that keeps the birds moving and reduces the count of floor eggs; and Easy-LIT, an electric scarifier that helps in simplifying the maintenance of litter without noise and dust, as well as without lifting the equipment and risking injury to the poultry. Octopus Biosafety SA was incorporated in 1987 and is headquartered in Auray, France.

Octopus Biosafety SA Fundamentals Summary

How do Octopus Biosafety's earnings and revenue compare to its market cap?
MLOCT fundamental statistics
Market cap€26.70m
Earnings (TTM)-€659.11k
Revenue (TTM)€385.11k
69.3x
P/S Ratio
-40.5x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLOCT income statement (TTM)
Revenue€385.11k
Cost of Revenue€721.41k
Gross Profit-€336.29k
Other Expenses€322.81k
Earnings-€659.11k

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0052
Gross Margin-87.32%
Net Profit Margin-171.15%
Debt/Equity Ratio-83.4%

How did MLOCT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/30 06:12
End of Day Share Price 2026/04/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Octopus Biosafety SA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.